CNMD earnings

CONMED Corporation (NYSE:CNMD) today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights Sales of $317.0 million decreased 1.3% year-over-year as reported and 2.9% in constant currency. Net sales growth was impacted by a $15.5 million decrease in sales from the exit of certain GI products. Domestic revenue decreased 5.8% year-over-year. Domestic sales growth was impacted by a $15.2 million decrease in sales from the exit of certain GI products. International revenue increased 4.7% year-over-year as reported and 1.0% in constant currency. International sales growth was impacted by a $0.3 million decrease in sales from the exit of c

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the first quarter 2026 after the market close on Wednesday, April 29, 2026. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a medic

CONMED Corporation (NYSE:CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2025. Fourth Quarter 2025 Highlights Sales of $373.2 million increased 7.9% year-over-year as reported and 7.1% in constant currency. Domestic revenue increased 1.4% year-over-year. International revenue increased 17.0% year-over-year as reported and 15.4% in constant currency. Diluted net earnings per share (GAAP) were $0.54, compared to diluted net earnings per share (GAAP) of $1.08 in the fourth quarter of 2024. Adjusted diluted net earnings per share(1) were $1.43, compared to adjusted diluted net earnings per share of $1.34 in the fourth quarter of 2

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the fourth quarter 2025 after the market close on Wednesday, January 28, 2026. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a me

CONMED Corporation (NYSE:CNMD) today announced financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Sales of $337.9 million increased 6.7% year-over-year as reported and 6.3% in constant currency. Domestic revenue increased 5.9% year-over-year. International revenue increased 7.8% year-over-year as reported and 6.8% in constant currency. Diluted net earnings per share (GAAP) were $0.09, compared to diluted net earnings per share (GAAP) of $1.57 in the third quarter of 2024. Adjusted diluted net earnings per share(1) were $1.08, compared to adjusted diluted net earnings per share of $1.05 in the third quarter of 2024. Subsequent to

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the third quarter 2025 after the market close on Wednesday, November 5, 2025. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a med

CONMED Corporation (NYSE:CNMD) today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Sales of $342.3 million increased 3.1% year-over-year as reported and 2.9% in constant currency. Domestic revenue increased 2.8% year-over-year. International revenue increased 3.4% year-over-year as reported and 2.9% in constant currency. Diluted net earnings per share (GAAP) were $0.69, compared to diluted net earnings per share (GAAP) of $0.96 in the second quarter of 2024. Adjusted diluted net earnings per share(1) were $1.15, compared to adjusted diluted net earnings per share of $0.98 in the second quarter of 2024. "We are enco

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the second quarter 2025 after the market close on Wednesday, July 30, 2025. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a medic

CONMED Corporation (NYSE:CNMD) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Sales of $321.3 million increased 2.9% year-over-year as reported and 3.8% in constant currency. Domestic revenue increased 4.2% year-over-year. International revenue increased 1.2% year-over-year as reported and 3.4% in constant currency. Diluted net earnings per share (GAAP) were $0.19, compared to diluted net earnings per share (GAAP) of $0.63 in the first quarter of 2024. Adjusted diluted net earnings per share(1) were $0.95, compared to adjusted diluted net earnings per share of $0.79 in the first quarter of 2024. "We had a good start t

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the first quarter 2025 after the market close on Wednesday, April 30, 2025. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a medical t

CONMED Corporation (NYSE:CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2024. Fourth Quarter 2024 Highlights Sales of $345.9 million increased 5.8% year over year as reported and 6.0% in constant currency. Domestic revenue increased 6.8% year over year. International revenue increased 4.4% year over year as reported and 5.0% in constant currency. Diluted net earnings per share (GAAP) were $1.08 compared to diluted net earnings per share (GAAP) of $1.05 in the fourth quarter of 2023. Adjusted diluted net earnings per share(1) were $1.34, an increase of 26.4% compared to the fourth quarter of 2023. Full-Year 2024 Highlights

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the fourth quarter 2024 after the market close on Wednesday, February 5, 2025. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a me

CONMED Corporation (NYSE:CNMD) today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Sales of $316.7 million increased 4.0% year-over-year as reported and 4.3% in constant currency. Diluted net earnings per share (GAAP) were $1.57 compared to diluted net earnings per share (GAAP) of $0.50 in the third quarter of 2023. Adjusted diluted net earnings per share(1) were $1.05, an increase of 16.7% compared to the third quarter of 2023. Announced COO Patrick Beyer to succeed Curt Hartman as President and CEO effective January 1, 2025, upon Mr. Hartman's retirement. "Our third quarter results were largely in line with our expecta

As a follow up to the Current Report on Form 8-K issued by the Company on September 30, 2024, CONMED Corporation (NYSE:CNMD) announced preliminary financial information for the third quarter of 2024. The Company expects revenue in the range of $315 million to $318 million and adjusted diluted net earnings per share growth in excess of its previously provided guidance of 9% to 11%. CONMED will report full financial results for the third quarter of 2024 after the market close on Wednesday, October 30, 2024. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-r

CONMED Corporation (NYSE:CNMD) today announced financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights Sales of $332.1 million increased 4.5% year-over-year as reported and 5.2% in constant currency. Domestic revenue increased 6.1% year-over-year. International revenue increased 2.6% year-over-year as reported and 4.0% in constant currency. Diluted net earnings per share (GAAP) were $0.96 compared to diluted net earnings per share (GAAP) of $0.43 in the second quarter of 2023. Adjusted diluted net earnings per share(1) were $0.98, an increase of 18.1% compared to the second quarter of 2023. "Our second quarter and first half of 2024 p

CONMED Corporation (NYSE:CNMD) today announced it will report financial results for the second quarter of 2024 after the market close on Wednesday, July 31, 2024. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a medical

CONMED Corporation (NYSE:CNMD) today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Sales of $312.3 million increased 5.7% year-over-year as reported and 5.9% in constant currency. Domestic revenue increased 7.2% year-over-year. International revenue increased 3.8% year-over-year as reported and 4.2% in constant currency. Diluted net earnings per share (GAAP) were $0.63 compared to diluted net earnings per share (GAAP) of $0.06 in the first quarter of 2023. Adjusted diluted net earnings per share(1) were $0.79, an increase of 19.7% compared to the first quarter of 2023. "2024 is off to a solid start as the quarter de

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the first quarter 2024 after the market close on Wednesday, April 24, 2024. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a medic

CONMED Corporation (NYSE:CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2023. Fourth Quarter 2023 Highlights Sales of $327.0 million increased 30.4% year over year as reported and 31.5% in constant currency Domestic revenue increased 33.3% year over year. International revenue increased 26.5% year over year as reported and 29.0% in constant currency. Diluted net earnings per share (GAAP) were $1.05 compared to diluted net earnings per share (GAAP) of $0.86 in the fourth quarter of 2022. Adjusted diluted net earnings per share(1) were $1.06, an increase of 152.4% compared to the fourth quarter of 2022. Full-Year 2023 Highli

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the fourth quarter 2023 after the market close on Wednesday, January 31, 2024. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a me

CONMED Corporation (NYSE:CNMD) today announced financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Highlights Sales of $304.6 million increased 10.7% year over year as reported and 11.9% in constant currency. Acquisitions contributed approximately 40 basis points of growth. Domestic revenue increased 9.5% year over year. International revenue increased 12.3% year over year as reported and 15.1% in constant currency. Diluted net earnings per share (GAAP) were $0.50 compared to diluted net earnings per share (GAAP) of $1.48 in the third quarter of 2022. Adjusted diluted net earnings per share(1) were $0.90, an increase of 16.9% compared to the

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the third quarter 2023 after the market close on Wednesday, October 25, 2023. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a med

CONMED Corporation (NYSE:CNMD) today announced financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Highlights Sales of $317.7 million increased 14.6% year over year as reported and 16.6% in constant currency. Acquisitions contributed approximately 400 basis points of growth. Domestic revenue increased 17.1% year over year. International revenue increased 11.7% year over year as reported and 16.0% in constant currency. Diluted net earnings per share (GAAP) were $0.43 compared to diluted net loss per share (GAAP) of $5.65 in the second quarter of 2022. Adjusted diluted net earnings per share(1) were $0.83, an increase of 9.2% compared to the seco

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the second quarter 2023 after the market close on Wednesday, July 26, 2023. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a medic

CONMED Corporation (NYSE:CNMD) today announced financial results for the first quarter ended March 31, 2023. First Quarter 2023 Highlights Sales of $295.5 million increased 21.9% year over year as reported and 25.1% in constant currency. Acquisitions contributed approximately 570 basis points of growth. Domestic revenue increased 25.4% year over year. International revenue increased 17.8% year over year as reported and 24.7% in constant currency. Diluted net earnings per share (GAAP) were $0.06, a decrease of 87.2% compared to the first quarter of 2022. Adjusted diluted net earnings per share(1) were $0.66, a decrease of 5.7% compared to the first quarter of 2022. "I am

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the first quarter 2023 after the market close on Wednesday, April 26, 2023. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a medic

CONMED Corporation (NYSE:CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2022. Fourth Quarter 2022 Highlights Fourth quarter 2022 sales significantly impacted by the implementation of new warehouse management software. Sales of $250.9 million decreased 8.4% year over year as reported and 7.0% in constant currency. Acquisitions contributed approximately 460 basis points of growth. Domestic revenue decreased 3.9% year over year. International revenue decreased 13.8% year over year as reported and 10.6% in constant currency. Diluted net earnings per share (GAAP) were $0.86, an increase of 14.7% compared to diluted net earnings per shar

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the fourth quarter 2022 after the market close on Thursday, February 2, 2023. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a medical

CONMED Corporation (NYSE:CNMD) today announced financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Highlights Sales of $275.1 million increased 10.6% year over year as reported and 12.1% in constant currency. Acquisitions contributed approximately 420 basis points of growth. Domestic revenue increased 14.2% year over year. International revenue increased 6.2% year over year as reported and 9.6% in constant currency. Diluted net earnings per share (GAAP) were $1.48, compared to diluted net earnings per share (GAAP) of $0.47 in the third quarter of 2021. Adjusted diluted net earnings per share(1) were $0.77, a decrease of 3.8% compared to adjusted d

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the third quarter 2022 after the market close on Wednesday, October 26, 2022. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a medical

Through this acquisition, CONMED acquires next generation bioinductive collagen scaffold technology for application in sports medicine soft tissue healing CONMED to host conference call today at 4:30 p.m. ET CONMED Corporation (NYSE:CNMD) today announced a definitive agreement to acquire privately held Biorez, Inc. (Biorez), on a cash-free, debt-free basis, for cash consideration of $85 million at closing, subject to adjustment, and up to an additional $165 million in growth-based earnout payments over a four-year period. The transaction is expected to be financed through the company's existing credit facility. The transaction is expected to close in early August 2022. Biorez is a me

CONMED Corporation (NYSE:CNMD) today announced financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Highlights Sales of $277.2 million increased 8.6% year over year as reported and 9.8% in constant currency. Acquisitions contributed approximately 80 basis points of growth. Domestic revenue increased 3.9% year over year. International revenue increased 14.7% year over year as reported and 17.2% in constant currency. Diluted net loss per share (GAAP) was $5.65 compared to diluted net earnings per share (GAAP) of $0.41 in the second quarter of 2021. Adjusted diluted net earnings per share(1) were $0.76, an increase of 7.0% over the second quarter of 2021

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the second quarter 2022 after the market close on Wednesday, July 27, 2022. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a medical t

CONMED Corporation (NYSE:CNMD) today announced financial results for the first quarter ended March 31, 2022. First Quarter 2022 Highlights Sales of $242.3 million increased 4.1% year over year as reported and 4.3% in constant currency. Domestic revenue increased 5.9% year over year. International revenue increased 2.2% year over year as reported and 2.6% in constant currency. Diluted net earnings per share (GAAP) were $0.47, an increase of 51.6% over the first quarter of 2021. Adjusted diluted net earnings per share(1) were $0.70, an increase of 11.1% over the first quarter of 2021. "I am pleased with our start to the year as we generated momentum and finished the quarter on a

CONMED Corporation (NYSE:CNMD) today announced that it will reschedule the reporting of its first quarter 2022 financial results due to a corporate conflict. The release of these financial results, which was previously scheduled for Wednesday, April 27, 2022, will now take place on Wednesday, May 4, 2022, after the market close. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. The Company is also providing updated dial-in information for the conference call. To participate in the conference call, dial 1-844-826-3033 (domestic) or 1-412-317-5185 (international) and enter the conference ID 10166354. This conference call will also be

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the first quarter 2022 after the market close on Wednesday, April 27, 2022. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call, dial 1-844-889-7792 (domestic) or +1-661-378-9936 (international) and refer to the passcode 9693807. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. A recording of the call will also be a

CONMED Corporation (NYSE:CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter 2021 Highlights Sales of $274.0 million increased 8.4% year over year as reported and 9.1% in constant currency. Domestic revenue increased 5.0% year over year. International revenue increased 12.7% year over year as reported and 14.3% in constant currency. Diluted net earnings per share (GAAP) were $0.75, compared to diluted net earnings per share of $0.81 during the fourth quarter of 2020. Adjusted diluted net earnings per share(1) were $1.07, compared to adjusted diluted net earnings per share of $0.84 during the fourth quarter of 2020.

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the fourth quarter 2021 after the market close on Wednesday, January 26, 2022. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call, dial 1-844-889-7792 (domestic) or +1-661-378-9936 (international) and refer to the passcode 5936618. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. A recording of the call will also b

CONMED Corporation (NYSE:CNMD) today announced financial results for the third quarter ended September 30, 2021. Third Quarter 2021 Highlights Sales of $248.8 million increased 4.6% year over year as reported and 4.3% in constant currency. Domestic revenue increased 1.6% year over year. International revenue increased 8.5% year over year as reported and 7.7% in constant currency. Diluted net earnings per share (GAAP) were $0.47, compared to diluted net earnings per share of $0.23 during the third quarter of 2020. Adjusted diluted net earnings per share(1) were $0.80, compared to adjusted diluted net earnings per share of $0.88 during the third quarter of 2020. "We faced a more

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the third quarter 2021 after the market close on October 27, 2021. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call, dial 1-844-889-7792 (domestic) or +1-661-378-9936 (international) and refer to the passcode 6396565. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. A recording of the call will also be available

CONMED Corporation (NYSE:CNMD) today announced financial results for the second quarter ended June 30, 2021. Second Quarter 2021 Highlights Sales of $255.2 million increased 61.7% year over year as reported and 58.2% in constant currency. Domestic revenue increased 64.2% year over year. International revenue increased 58.6% year over year as reported and 50.7% in constant currency. Diluted net earnings per share (GAAP) were $0.41, compared to a diluted net loss per share of $0.96 during the second quarter of 2020. Adjusted diluted net earnings per share(1) were $0.71, compared to an adjusted diluted net loss per share of $0.07 during the second quarter of 2020. "Our solid secon